These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16253480)

  • 1. Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever.
    Jun HX; Zhixiang S; Chun W; Reksodiputro AH; Ranuhardy D; Tamura K; Matsumoto T; Lee DG; Purushotaman SV; Lim V; Ahmed A; Hussain Y; Chua M; Ong A; Liu CY; Hsueh PR; Lin SF; Liu YC; Suwangool P; Jootar S; Picazo JJ
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S128-32; discussion S133-40. PubMed ID: 16253480
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of the febrile neutropenic patient.
    Picazo JJ;
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
    Kalman D; Barriere SL
    J Infect Dis; 1991 Jan; 163(1):201-3. PubMed ID: 1984470
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
    Link H; Böhme A; Cornely OA; Höffken K; Kellner O; Kern WV; Mahlberg R; Maschmeyer G; Nowrousian MR; Ostermann H; Ruhnke M; Sezer O; Schiel X; Wilhelm M; Auner HW; ;
    Ann Hematol; 2003 Oct; 82 Suppl 2():S105-17. PubMed ID: 13680173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
    Croydon E; Weerts D
    Chemioterapia; 1987 Jun; 6(2 Suppl):405-7. PubMed ID: 3334585
    [No Abstract]   [Full Text] [Related]  

  • 7. Fosfomycin in paediatric cancer patients: a feasible alternative to glycopeptides?
    Hepping N; Simon A
    Int J Antimicrob Agents; 2009 Apr; 33(4):389. PubMed ID: 19097756
    [No Abstract]   [Full Text] [Related]  

  • 8. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?
    Pizzo PA
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i16-7. PubMed ID: 19372174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial therapy in neutropenia].
    Maschmeyer G; Vogt K; Hahn H; Dörken B
    Dtsch Med Wochenschr; 1997 Jul; 122(27):864-9. PubMed ID: 9280698
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of antibiotics in febrile neutropenic patients with cancer].
    Villegas JB; Gavilán MG
    Rev Esp Quimioter; 1999 Jun; 12(2):104-6. PubMed ID: 10562669
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of bacterial infections in acute leukemia.
    Bodey GP
    Leukemia; 1992; 6 Suppl 2():17-21. PubMed ID: 1578924
    [No Abstract]   [Full Text] [Related]  

  • 13. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
    Sinkó J; Kullberg BJ; Edwards JE; Anaissie E
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i41-3. PubMed ID: 19372182
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of bacterial infections in neutropenic and immunocompromised patients].
    Helbig W; Tauchnitz R
    Z Gesamte Inn Med; 1992 Sep; 47(9):417-21. PubMed ID: 1441670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.
    Tam CS; O'Reilly M; Andresen D; Lingaratnam S; Kelly A; Burbury K; Turnidge J; Slavin MA; Worth LJ; Dawson L; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):90-101. PubMed ID: 21272173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment].
    Durnaá B; Dzierzanowska D
    Wiad Lek; 2006; 59(7-8):506-11. PubMed ID: 17209349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America.
    Hughes WT; Armstrong D; Bodey GP; Brown AE; Edwards JE; Feld R; Pizzo P; Rolston KV; Shenep JL; Young LS
    Clin Infect Dis; 1997 Sep; 25(3):551-73. PubMed ID: 9314442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical versus preemptive antifungal therapy for fever during neutropenia.
    Marr KA; Leisenring W; Bow E
    Clin Infect Dis; 2009 Oct; 49(7):1138-9; author reply 1139-40. PubMed ID: 19739966
    [No Abstract]   [Full Text] [Related]  

  • 19. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
    Bodey GP
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i3-13. PubMed ID: 19372179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of febrile neutropenia].
    Urabe A
    Rinsho Ketsueki; 2009 Feb; 50(2):69-72. PubMed ID: 19265296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.